Clinical features |
Serum potassium level 5 to 7 mEq/L – Generally asymptomatic. |
Serum potassium level greater than 7 mEq/L – Muscle weakness, paralysis, and cardiac changes on ECG and arrhythmias. Sudden arrest may occur. |
Causes |
Pseudohyperkalemia, usually due to hemolysis of the blood specimen, is the most likely cause of an elevated serum or plasma potassium level in children. It does not reflect true hyperkalemia and is not associated with cardiac conduction disturbances. |
The 2 major mechanisms of true hyperkalemia and their major causes are:
|
Laboratory evaluation |
Laboratory tests are based on probable etiology. All patients with true hyperkalemia should have the following tests obtained:
In cases where rhabdomyolysis is suspected, the following studies are also indicated:
In cases where adrenal insufficiency is suspected, additional testing includes:
|
ECG changes* |
ECG findings commonly progress as follows:
|
Management |
Confirm that the patient is truly hyperkalemic (ie, exclude pseudohyperkalemia) by obtaining a venous or arterial blood sample that is not hemolyzed for rapid analysis. |
Obtain ECG, and place patient on a cardiac monitor. |
The following specific therapies are listed according to their effectiveness and rapidity of action; the choice of intervention depends on the severity of ECG changes and muscle weakness: |
Stabilize cardiac membranes with calcium:
|
Shift potassium into cells: |
Insulin and glucose – Onset of action is 10 to 20 minutes. Only give if significant ECG changes or confirmed serum potassium ≥7 mEq/L. Give regular insulin (dose of 0.1 units per kg, maximum dose of 10 units) along with dextrose (glucose) dose of 0.5 g/kg over 30 minutes. The administration of dextrose is based on the age of the patient as follows:
For patients with severe acute symptoms, ECG changes, arrhythmias, or impending arrest – Larger doses of regular insulin (0.2 units/kg) and dextrose (1 g/kg, 10 mL/kg of 10% dextrose or 4 mL/kg of 25% dextrose) can be administered. Repeat dosing can be given after 30 minutes if needed. The major adverse effect is hypoglycemia, and serum glucose level should be monitored closely and additional dextrose administered as needed. |
Beta-2 agonist – Onset of action is 20 to 30 minutes. Give nebulized albuterol (salbutamol) with dosing based on patient weight as follows:
Inhalation may be repeated after 20 minutes. Inhaled albuterol may also be administered by metered-dose inhaler as 4 to 8 puffs with spacer. |
Sodium bicarbonate – Onset of action is 15 minutes. Provides minimal effect on shifting potassium intracellularly and should not be the only therapy used in the management of hyperkalemia, even in acidotic children. Give 1 mEq/kg (1 mmol/kg). Maximum single dose of 50 mEq (50 mmol), which can be provided as 1 mL/kg of 8.4% solution or, for children younger than 6 months of age, 2 mL/kg of 4.2% solution administered over 10 to 15 minutes. A repeat dose may be given 10 to 15 minutes after last administration. Do not give in the same IV line as calcium, because of a risk of precipitation. |
Remove potassium; since the effect of above therapies is transient, treatments to remove potassium are also required. |
Stop all potassium intake. |
Loop diuretic – Provides only limited short-term effect. Give furosemide 1 mg/kg IV (maximum single dose of 40 mg); higher dose may be required with kidney function impairment; fluid losses must be replaced unless the patient is volume expanded. The onset of effect is 1 to 2 hours. May be repeated after 6 hours. |
Cation exchange resin (sodium polystyrene sulfonate) – Give sodium polystyrene sulfonate (without sorbitol) at a dose of 1 g/kg (maximum dose of 30 g) orally, through nasogastric tube, or as a retention enema. 1 g of resin will bind 1 mEq (mmol) of potassium. Onset is approximately 1 to 2 hours; may repeat dose after 4 to 6 hours based on repeat serum potassium. Sodium polystyrene sulfonate should not be used in preterm neonates, term neonates with intestinal hypomotility and/or those at risk for necrotizing enterocolitis, postoperative patients, or those with bowel obstruction or ileus. Sorbitol can cause intestinal necrosis and should be avoided. A laxative that contains no magnesium or potassium (eg, lactulose) is an alternative to sorbitol use to prevent colonic impaction. |
Hemodialysis – In children unresponsive to diuretic or cation exchange resin therapy, or with severe kidney function impairment, dialysis may be necessary to remove excess potassium from the body. Hemodialysis is the preferred modality to reduce potassium levels as it is the quickest and most controlled kidney replacement treatment. |
ACTH: adrenocorticotrophic hormone; BUN: blood urea nitrogen; D5W: dextrose 5% solution in water; ECG: electrocardiogram; IO: intraosseous; IV: intravenous; NS: normal saline.
* Large interpatient variability exists in the relationship between the serum potassium and ECG changes; at a given serum potassium, ECG changes are more common with acute elevations and less common with chronic elevations (eg, chronic kidney disease). Infants generally have a higher range of normal potassium levels, so ECG changes are usually observed at higher values.
¶ Conversions: 10% calcium gluconate = 100 mg/mL calcium gluconate = 9.3 mg/mL elemental calcium = 0.23 mmol/mL calcium; suggested dose of 60 mg/kg (perfusing patient) is equivalent to a dose of elemental calcium 5 mg/kg (0.15 mmol/kg) up to a maximum of 180 mg elemental calcium (4.5 mmol) per dose.
Δ Conversions: 10% calcium chloride = 100 mg/mL calcium chloride = 27.3 mg/mL elemental calcium = 0.68 mmol/mL calcium; suggested dose of 20 mg/kg (cardiac arrest) is equivalent to a dose of elemental calcium 5 mg/kg (0.15 mmol/kg) up to a maximum of 540 mg elemental calcium (14 mmol) per dose.آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟